PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma
NCT02492815
·
clinicaltrials.gov ↗
COMPLETED
Status
1773
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Sponsor
Bristol-Myers Squibb